IRP Vaccine Research Stretches Back to the NIH’s Birth
By Michele Lyons
Monday, May 18, 2020
Over the past few months, the world has gained a new appreciation for the long, difficult process of producing vaccines as it waits anxiously for one that will provide protection from the novel coronavirus. With the NIH Vaccine Research Center’s efforts to develop a COVID19 vaccine drawing a huge amount of media attention, it is easy to forget that the IRP has been making vital contributions to vaccine development for more than 100 years. These efforts have helped produce vaccinations for smallpox, rubella, hepatitis A, whooping cough, human papillomavirus (HPV), and several other diseases. Read on for a visual journey through the history of IRP vaccine research.
By Michael Gottesman
Tuesday, April 4, 2017
Last month I moderated our annual retreat with the NIH Scientific Directors, those individuals tasked with leading their Institute or Center (IC)-based intramural research program. We were joined by many of the IC Clinical Directors. And this year we decided to do something a little different: listen to a series of talks about exciting, new IRP research.
By IRP Staff Blogger
Tuesday, January 26, 2016
In his recent State of the Union address, President Barack Obama called America to action and asserted that our researchers can find the cure for cancer, a sentiment that received a standing ovation. We believe that Obama is right.
By Craig Myrum
Tuesday, January 5, 2016
Speaking at the NIH Research Festival in September, Michael Gottesman, M.D., the NIH Deputy Director for Intramural Research said, “The real research is being done by the fellows, by the students.” The FARE awards are meant to commend those researchers doing outstanding work at the NIH.
By IRP Staff Blogger
Wednesday, January 21, 2015
Long recognized as essential to global health, vaccines protect individuals and populations from contagion and the reappearance of eradicated diseases. Vaccination against deadly diseases prevents two to three million deaths worldwide every year, and there are significant economic benefits as well. In the United States, every dollar spent on the routine childhood immunization program saves society more than $16 in future costs.
By IRP Staff Blogger
Wednesday, December 17, 2014
The turn of the 20th century brought exponential advancements in technology and science. While intrepid explorers like Cook and Peary journeyed over the tundra and ice in search of the North Pole—at that time considered the final frontier of land exploration—the budding National Institutes of Health (NIH) was also journeying into the unknown with a charge to protect the public from organisms existing at the very edges of life.
